Of note, EIF1AX mutations were found almost exclusively in HRAS-, KRAS-, and NRAS-mutant thyroid cancers (p<0.05), whereas STK11 mutations were found in greater proportion of HRAS-mutant NSCLC compared to the other HRAS-mutant cancer types. This evidence concerns the gene NRAS and thyroid cancer.